The Clinical Chronicle

The Clinical Chronicle Podcast delivers concise, evidence-based updates from the frontlines of medicine. Hosted by Dr. Vijay Nethala, each episode breaks down the latest clinical research and guidelines across specialties—making complex medical advances clear and actionable. Whether you’re a resident, practicing physician, or healthcare professional, tune in for insights that help you stay ahead in patient care, with a focus on practical impact and cutting-edge science. Stay informed. Stay inspired. Join Dr. Nethala as he explores the evolving landscape of medicine, one breakthrough at a time.

The Clinical Chronicle is a news podcast hosted by Vijay Nethala, with 5 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

Vijay Nethala hosts The Clinical Chronicle, a news show with 5 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Episode #1

  Practice-Changing Clinical Updates 2026: Stroke Guidelines, Hyponatremia Correction, Lung Cancer Screening, and GLP-1 in Colon Cancer

  Feb 28, 202613 minS2

  <p>Welcome to Season 2, Episode 1 of The Clinical Chronicle.</p><p>This episode delivers major practice-changing updates in medicine for 2026, including the new AHA and ASA acute ischemic stroke guideline, evolving evidence on sodium correction in severe hyponatremia, and why current lung cancer screening criteria may be missing more than 60 percent of patients at diagnosis.</p><p>We break down expanded eligibility for endovascular thrombectomy in larger core strokes, the shift toward dual antiplatelet therapy over thrombolysis for minor nondisabling stroke, and updated blood pressure management recommendations in acute ischemic stroke. These changes are highly relevant for hospitalists, emergency physicians...

  ListenShow Notes
• 

  Episode #10

  The Biggest Shifts in Medicine This Year: 2025

  Dec 25, 202511 minS1

  <p>From blood-based diagnostics and durable disease-modifying therapy in Alzheimer’s disease to age-dependent cardiovascular protection with GLP-1 and SGLT2 therapies, this episode captures the most practice-changing advances of 2025. We unpack 10 high-impact updates, including expanded SGLT2 use across the full spectrum of chronic kidney disease, CDC-endorsed twice-yearly injectable HIV prevention, phenotype-driven biologics in COPD, and long-awaited survival gains in small cell lung cancer redefining frontline and relapsed care. Together, these shifts signal a decisive move toward earlier intervention, precision treatment, and trajectory-altering outcomes across major disease states.</p>

  ListenShow Notes
• 

  Episode #9

  10 Practice-Changing Studies Every Clinician Should Know – August 2025

  Aug 13, 202522 minS1

  <p>From targeted therapies in HER2-mutant lung cancer to the latest Alzheimer’s data with Kisunla, this month’s breakthroughs could reshape patient care. We unpack 10 high-impact studies and trials, including new insights on ILD–cancer links, the HOPE trial in late-window stroke thrombolysis, phenotype-specific benefits of CPAP, and kidney-protective strategies in diabetic CKD. Designed for clinicians, this deep dive blends the latest evidence with real-world clinical implications.</p>

  ListenShow Notes
• 

  Episode #8

  Edition 8: The New Pill, the Shot, and the Cure: Breakthroughs Shaping Medicine in 2025

  Jul 7, 20258 minS1

  <p>From a once-monthly GLP-1/GIP driving 16% weight loss to a twice-yearly HIV PrEP injection, this episode unpacks the most practice-changing updates in internal medicine. We cover new evidence in obesity care, MASH reversal, stroke anticoagulation timing, sarcoidosis management, COPD biologics, and the cardioprotective power of oral semaglutide. Plus, hear what every rising PGY-2 should know heading into senior year.</p>

  ListenShow Notes
• 

  Episode #7

  Edition 7: TAVR, IV vs IO, ERCP risk plateaus, dementia and cannabis.

  May 26, 202518 minS1

  <p>From FIT screening outpacing colonoscopy in participation to anti-CD20 drugs showing lasting MS control at 7+ years, this edition brings clarity to complex clinical choices. We examine how metabolic syndrome increases young-onset dementia risk by 24%, why post-ERCP pancreatitis rates haven’t budged in two decades, and the unchanged survival edge between IO and IV access in cardiac arrest.</p><p>As phthalates in plastics are linked to 350,000 heart deaths and cannabis use raises dementia odds, we separate correlation from causation. Meanwhile, fecal therapy via colonoscopy proves safe and 95% effective for recurrent C. diff, and FDA expands TAVR for asymptomatic aortic st...

  ListenShow Notes

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.